Corina E. Dutcus
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 46
- Cancer Immunotherapy and Biomarkers 24
- Cancer Treatment and Pharmacology 9
-
- Renal cell carcinoma treatment 19
- Lung Cancer Treatments and Mutations 14
- Co-authors
- Matthew H. Taylor (36 shared papers)Marcia S. Brose (23 shared papers)Makoto Tahara (25 shared papers)Naomi Kiyota (19 shared papers)Lori J. Wirth (18 shared papers)Andrew G. Gianoukakis (12 shared papers)Steven I. Sherman (15 shared papers)Bruce Robinson (14 shared papers)
- Journals
- Journal of Clinical Oncology (42 papers)Annals of Oncology (20 papers)European Journal of Cancer (7 papers)Cancer (3 papers)British Journal of Cancer (3 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Corina E. Dutcus
108 papers receiving 7.2k citations
Corina E. Dutcus's Hit Papers
Peers
Comparison fields: 5 of 102
- Hepatology 1.2k
- Oncology 3.7k
- Endocrinology, Diabetes and Metabolism 1.8k
- Cancer Research 1.3k
- Pulmonary and Respiratory Medicine 2.4k
Countries citing papers authored by Corina E. Dutcus
This map shows the geographic impact of Corina E. Dutcus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corina E. Dutcus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corina E. Dutcus more than expected).
Fields of papers citing papers by Corina E. Dutcus
This network shows the impact of papers produced by Corina E. Dutcus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corina E. Dutcus. The network helps show where Corina E. Dutcus may publish in the future.
Co-authors
The 25 scholars most cited alongside Corina E. Dutcus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer Hit paper breakdown → | 2015 | 1408 |
| 2 | Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma Hit paper breakdown → | 2020 | 850 |
| 3 | Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Hit paper breakdown → | 2011 | 807 |
| 4 | Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial Hit paper breakdown → | 2015 | 688 |
| 5 | Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 360 |
| 6 | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer Hit paper breakdown → | 2020 | 359 |
| 7 | 2015 | 333 | |
| 8 | Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors Hit paper breakdown → | 2020 | 306 |
| 9 | 2017 | 143 | |
| 10 | 2019 | 97 | |
| 11 | 2019 | 93 | |
| 12 | 2019 | 86 | |
| 13 | 2018 | 84 | |
| 14 | 2018 | 80 | |
| 15 | 2017 | 80 | |
| 16 | 2020 | 74 | |
| 17 | 2018 | 68 | |
| 18 | 2016 | 68 | |
| 19 | 2017 | 62 | |
| 20 | 2017 | 60 |
About Corina E. Dutcus
Corina E. Dutcus is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research, having authored 110 papers that have together received 7.4k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (35 papers), Cancer Immunotherapy and Biomarkers (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Renal cell carcinoma treatment (19 papers), Lung Cancer Treatments and Mutations (14 papers), Endometrial and Cervical Cancer Treatments (11 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Hepatology (1.2k citations), Oncology (3.7k citations), Endocrinology, Diabetes and Metabolism (1.8k citations), Cancer Research (1.3k citations) and Pulmonary and Respiratory Medicine (2.4k citations). Corina E. Dutcus has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Matthew H. Taylor, Marcia S. Brose, Makoto Tahara, Naomi Kiyota, Lori J. Wirth, Andrew G. Gianoukakis, Steven I. Sherman, Bruce Robinson, Martin Schlumberger and Vicky Makker. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.